For the first time, scientists discover that a subset of a common blood cancer is more deadly in women than in men — and find a new targeted treatment approach
The Josep Carreras Leukaemia Research Institute, new Member Institution at the International Cancer Proteogenome Consortium of the National Cancer Institute
